MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-16-0010491
Karak Pharmaceuticals Private Limited
Karak Pharmaceuticals Private Limited - trading in Midnapore, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.46 Cr
▲ 9% YoY
Net profit · FY 2024
₹3.82 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹7.33 Lakh
EBITDA margin 1%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹7.1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
29 yrs
Est. 1997
Directors on board
2
As per MCA filings
About Karak Pharmaceuticals Private Limited
Data last updated:
Karak Pharmaceuticals Private Limited is a private limited company based in Midnapore, West Bengal, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 13 March 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1997PTC083329. Its GSTIN is 19AABCK1722B1Z3 (West Bengal).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹7.1 Lakh. It is led by directors Arun Kumar Roy and Swapan Kumar Karak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bibiunj P O Midnapur, Midnapore, West Bengal, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.46 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹3.82 Lakh (net margin 0.5%) and EBITDA of ₹7.33 Lakh (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Karak Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-16-0010491). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232WB1997PTC083329
Registration Number 083329
Incorporation Date 13 March 1997
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-16-0010491
Recognitions & Rankings of Karak Pharmaceuticals
Contact details
Karak Pharmaceuticals Private Limited's registered office is in Midnapore, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBibiunj P O Midnapur, Midnapore, West Bengal, India
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Karak Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Karak Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Karak Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Karak Pharmaceuticals Private Limited, buy the company report.
Financials of Karak Pharmaceuticals Private Limited
FY 2025 filings availableKarak Pharmaceuticals Private Limited reported revenue of ₹7.46 Cr (up 9% YoY) for FY 2024.
Revenue · FY 2024
₹7.46 Cr ▲ 9%
Net profit · FY 2024
₹3.82 Lakh margin 0.5%
EBITDA · FY 2024
₹7.33 Lakh margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 4%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 7%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 9% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Karak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Karak Pharmaceuticals Private Limited
Karak Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar Roy | Director | 13 Mar 1997 | 29 Years 7 Months | Current |
| Swapan Kumar Karak Also directs: Psthree Agro Private Limited | Director | 01 Mar 2007 | 19 Years 7 Months | Current |
Peer comparison
Karak Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Manufacturing industry (Formulations, Industrial Chemicals, Leather), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JMS Medicon Private Limited | ₹7.46 Cr (FY 2024) | 20.0% | New Delhi, Delhi, India | |||
| Rinting Harmony Exim India Private Limited | ₹7.46 Cr (FY 2025) | 963.0% | Bulandshahr, Uttar Pradesh, India | |||
| Karak Pharmaceuticals Private Limitedthis company | ₹7.46 Cr (FY 2024) | ₹3.82 Lakh | 0.5% | 9.0% | Midnapore, West Bengal, India | |
| Kindcare Drugs Private Limited | ₹7.44 Cr (FY 2025) | -24.0% | Delhi, India |
To see the full peer comparison of Karak Pharmaceuticals Private Limited, buy the company report.
Auditor
Karak Pharmaceuticals Private Limited is audited by S BASU ROY & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S BASU ROY & CO | FY 2017 | 302112E |
Shareholding
The shareholding of Karak Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Karak Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Sep 2003 | 90248444 | United Bank of India | ₹20 Lakh | Open |
To see the full charge records of Karak Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Karak Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Karak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Karak Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCK1722B1Z3 | West Bengal | Active | 11 Jul 2017 |
To see the full GST registrations and return filing status of Karak Pharmaceuticals Private Limited, buy the company report.
Recent activity
Karak Pharmaceuticals Private Limited has 2 board changes on record since 1997: 2 appointments. The latest: Swapan Kumar Karak was appointed as Director on 01 Mar 2007.
AGM
Karak Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Karak Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Charges
A charge with United Bank Of India of Rs. 20.00 Lakh registered on 26 Sep 2003 with Charge ID 90248444 was modified on 01 Oct 2008.
Appointed
Swapan Kumar Karak was appointed as Director.
Charges
A charge with United Bank Of India amounted to Rs. 20.00 Lakh with Charge ID 90248444 was registered on 26 Sep 2003.
Appointed
Arun Kumar Roy was appointed as Director.
Incorporation
13 Mar 1997
Karak Pharmaceuticals Private Limited was registered on 13 Mar 1997 with Roc Kolkata Ii & aged 29 years 7 months as per MCA records.
Frequently asked questions
Karak Pharmaceuticals is an active private limited company based in Midnapore, West Bengal, India. The company works in other wholesale, within the trading industry. It was incorporated on 13 March 1997 (29+ years old) and is registered under CIN U24232WB1997PTC083329.
Karak Pharmaceuticals has 2 current directors:
- Arun Kumar Roy - Director
- Swapan Kumar Karak - Director
The latest financial statements of Karak Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Karak Pharmaceuticals is 19AABCK1722B1Z3, registered in West Bengal.
The CIN (Corporate Identification Number) of Karak Pharmaceuticals is U24232WB1997PTC083329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Karak Pharmaceuticals was incorporated on 13 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Karak Pharmaceuticals by revenue are JMS Medicon Private Limited, Rinting Harmony Exim India Private Limited, Kindcare Drugs Private Limited, all in the Manufacturing industry (Formulations, Industrial Chemicals, Leather), with the same principal business activity (wholesale trading).
Swapan Kumar Karak was appointed as Director on 01 Mar 2007. Arun Kumar Roy was appointed as Director on 13 Mar 1997.
Yes, Karak Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-WB-16-0010491).
The registered office of Karak Pharmaceuticals is at Bibiunj P O Midnapur, Midnapore, West Bengal, India.
Karak Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages